Ancient protein holds the key to unlocking more powerful cancer immunotherapies
Photo: National Institute of Allergy and Infectious Diseases / Unsplash
Researchers have discovered that an ancient protein called C3 can block immune-suppressing cells within tumors, allowing cancer immunotherapies to work much more effectively. By successfully replicating this natural process in resistant tumors, scientists have significantly improved survival rates in preclinical trials, paving the way for more resilient cancer treatments.
Researchers have discovered that an ancient protein called C3 can block immune-suppressing cells within tumors, allowing cancer immunotherapies to work much more effectively. By successfully replicating this natural process in resistant tumors, scientists have significantly improved survival rates in preclinical trials, paving the way for more resilient cancer treatments.